Patient will present as → a 24-year-old with increasing cough for 3 weeks. The cough comes and goes sometimes lasting for 10 minutes and causing gasping inhalations. The cough was preceded by a mild cough and cold 2 weeks ago. She has completed all immunizations required to attend school and has no known drug allergies
Patient will present with → severe paroxysmal cough followed by an inspiratory high-pitched whoop if untreated will develop a chronic cough lasting for weeks (watch video).
Caused by highly contagious gram-negative bacteria Bordetella Pertussis
- Consider pertussis in adults with cough > 2 weeks
Diagnosis is confirmed by nasopharyngeal secretions
- In the setting of a pertussis outbreak or known close contact with a confirmed case, the presence of a cough lasting ≥2 weeks is sufficient for clinical diagnosis (even in the absence of other symptoms)
- For patients with less than two weeks of cough in whom there is a clinical concern for pertussis, perform both culture and PCR for B. pertussis
- For patients with two to four weeks of cough, perform both culture and PCR
- For patients with more than four weeks of cough, only serology is useful
Treat with macrolide antibiotic clarithromycin or azithromycin
- Supportive care with steroids and/or beta2 agonists
"What do you do if your patient is a 4 year old diagnosed with pertussis and attends a daycare? All close contacts of a patient with pertussis should be treated with macrolide prophylaxis regardless of age, immunization history or symptoms."
Children should get 5 doses of DTaP vaccine: one dose at each of the following ages:
- 2 months
- 4 months
- 6 months
- 15–18 months
- 4–6 years
Adolescents 11 through 18 years of age (preferably at age 11-12 years) should receive a single booster dose of Tdap
- One dose of Tdap is also recommended for adults 19 years of age and older who did not get Tdap as an adolescent
- Expectant mothers should receive Tdap during each pregnancy, preferably at 27 through 36 weeks
- Tdap should also be given to 7-10-year-olds who are not fully immunized against pertussis
- Tdap can be given no matter when Td was last received
|Bordetella pertussis is a gram negative coccobacillus that is the causative agent of whooping cough. This organism is typically cultured on specialized medium called Bordet Gengou agar. Bordetella pertussis produces the pertussis toxin, which is an ADP ribosylating AB toxin that is involved in the colonization of the respiratory tract and the establishment of infection. This toxin catalyzes the ADP ribosylation of the Gi subunit, which prevents the G proteins from interacting with G protein coupled receptors on the cell membrane. The Gi subunits remain locked in an inactive or off state and are therefore unable to inhibit adenylyl cyclase activity leading to increased concentrations of cAMP. The increase in intracellular cAMP has several systemic effects including lymphocytosis and an increase in insulin leading to hypoglycemia.
The first 1-2 weeks of infection is typically called the catarrhal phase. The patient is usually most contagious during this stage of infection and signs and symptoms include nasal congestion, rhinorrhea, sneezing, and a low-grade fever. The catarrhal phase is followed by a paroxysmal phase which occurs during weeks 2-5 of infection. The paroxysmal phase is characterized by paroxysms of intense coughing lasting up to several minutes, occasionally followed by a loud inspiratory whooping sound, characteristic of this infection.
Antibiotic use can hasten the eradication of the bacteria and help prevent spread. Erythromycin is one of the preferred agents for patients aged 1 month or older.
While mosquitoes have been implemented in the spread of several infectious diseases, pertussis is not one of them.
Dogs and cats
Contact with dogs and cats has lead to the development of upper and lower respiratory infections that are caused by Bordetella bronchiseptica, but not pertussis.
White-tailed deer are part of the transmission cycle for Lyme disease, not pertussis.
See A for explanation.
See A for explanation.
See A for explanation.
Isolation of contacts is impractical and unnecessary.
Observation and treatment only if symptomatic
Pertussis is rarely diagnosed before the paroxysmal stage, by which time exposure of contacts to the pathogen is assured.
Supportive care only
While supportive care is essential in those contacts with symptoms, macrolide prophylaxis is mandatory in all contacts to prevent further spread of the illness.
Ceftriaxone does not eradicate Bordetella pertussis.
Ampicillin may be used for macrolide-intolerant patients however it is not the drug of choice.
Gentamicin does not eradicate Bordetella pertussis.